Lisa Kelly-Croswell - 18 Jul 2022 Form 3 Insider Report for Eiger BioPharmaceuticals, Inc.

Role: Director
Signature: /s/ Sriram Ryali, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 18 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Jul 2022, 18:58:02 UTC
Previous filing: 13 Jun 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney